Get started
Author

Jasmine Gratton

Observed names: Gratton, Jasmine, Gratton, Jasmine Elina, J G Gratton, J Gratton, J. Gratton, J.Gratton, Jasmin Gratton
ORCID: 0000-0002-9781-9762
Observed ORCID: 0000-0002-9781-9762
OpenAlex ID: A5067023397
Identifying and visualising multimorbidity and comorbidity patterns in patients in the English National Health Service: a population-based study
2022 · Valerie Kuan, Spiros Denaxas, et al. · The Lancet Digital Health · 180
PDF
Optimized Sample Handling Strategy for Metabolic Profiling of Human Feces
2016 · Jasmine Gratton, Jutarop Phetcharaburanin, et al. · Analytical Chemistry · 176
Performance of polygenic risk scores in screening, prediction, and risk stratification: secondary analysis of data in the Polygenic Score Catalog
2023 · Aroon D Hingorani, Jasmine Gratton, et al. · BMJ Medicine · 98
PDF
Cardiovascular risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care settings
2022 · Katarzyna Dziopa, Folkert W. Asselbergs, et al. · Diabetologia · 98
PDF
Genome-wide association study meta-analysis provides insights into the etiology of heart failure and its subtypes
2025 · Albert Henry, Xiaodong Mo, et al. · Nature Genetics · 58
Prevalence of FH-Causing Variants and Impact on LDL-C Concentration in European, South Asian, and African Ancestry Groups of the UK Biobank—Brief Report
2023 · Jasmine Gratton, Steve E. Humphries, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 23
PDF
A Machine Learning Model to Aid Detection of Familial Hypercholesterolemia
2023 · Jasmine Gratton, Marta Futema, et al. · JACC Advances · 12
PDF
LDL-C Concentrations and the 12-SNP LDL-C Score for Polygenic Hypercholesterolaemia in Self-Reported South Asian, Black and Caribbean Participants of the UK Biobank
2022 · Jasmine Gratton, Chris Finan, et al. · Frontiers in Genetics · 8
Performance of polygenic risk scores in screening, prediction, and risk stratification
2022 · AD. Hingorani, J. Gratton, et al. · medRxiv · 7
PDF
Calculating daily dose in the Observational Medical Outcomes Partnership Common Data Model
2024 · Theresa Burkard, Kim López‐Güell, et al. · Pharmacoepidemiology and Drug Safety · 6
Mapping the aetiological foundations of the heart failure spectrum using human genetics
2023 · Albert Henry, Xiaodong Mo, et al. · medRxiv · 6
PDF
Trends in prescription opioid use in Europe: A DARWIN EU® multinational cohort study including seven European countries
2025 · Junqing Xie, Mike Du, et al. · Frontiers in Pharmacology · 5
PDF
EPH114 Facilitating Real-World Data Discoverability and Transparency of Real-World Evidence to Support Research and Regulatory Decision-Making: The HMA-EMA Real-World Data Catalogues of Data Sources and Studies
2024 · S Simou, E Kontsioti, et al. · Value in Health · 2
PDF
Modelling a two-stage adult population screen for autosomal dominant familial hypercholesterolaemia: cross-sectional analysis within the UK Biobank
2023 · Jasmine Gratton, Steve E Humphries, et al. · BMJ Public Health · 2
PDF
Combining stacked polygenic scores with clinical risk factors improves cardiovascular risk prediction in people with type 2 diabetes
2022 · K Dziopa, N Chaturvedi, et al. · medRxiv · 2
PDF
A machine learning model to aid detection of familial hypercholesterolaemia
2022 · Jasmine Gratton, Marta Futema, et al. · medRxiv · 2
PDF
Advancing pharmacogenomics in medicines regulation and clinical practice: a call for collaborative action
2025 · Jasmine Gratton, Peter Arlett, et al. · Nature Reviews Drug Discovery · 1
Proteogenomic analysis in population biobanks identifies new therapeutic targets across heart failure subtypes
2024 · A Henry, C Finan, et al. · European Heart Journal · 1
Cardiovascular risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care setting
2021 · K D Dziopa, F W A Asselbergs, et al. · European Heart Journal · 1
PDF
Trends of Prescription Opioid Use in Europe: A DARWIN EU® Multinational Cohort Study Including 7 European Countries
2024 · Junqing Xie, Mike Du, et al. · SSRN Electronic Journal
Prevalence of familial hypercholesterolaemia (FH)-causing variants and impact on LDL-C concentration in European, South Asian, and African ancestry groups of the UK Biobank
2023 · J. Gratton, S.E. Humphries, et al. · Atherosclerosis Plus
How many individuals with Familial Hypercholesterolaemia (FH) need to be identified to achieve the NHS 2019 Long Term Plan ambition?
2023 · S.E. Humphries, J.Gratton, et al. · Atherosclerosis Plus
Frequency of variants causing familial hypercholesterolaemia (FH) and impact on LDL-C concentration in individuals of South Asian and African ancestry in the UK Biobank
2023 · M. Futema, S. Humphries, et al. · Atherosclerosis
Stacking multiple prediction models to optimise performance in local settings: exemplars in cardiometabolic disease
2023 · Sreejita Ghosh, Jasmine Gratton, et al. · medRxiv
PDF
Modelling a two-stage screen for autosomal dominant familial hypercholesterolaemia (FH) in UK Biobank
2022 · J. Gratton, S.E. Humphries, et al. · Atherosclerosis Plus
PDF
Works count: 28
Citation count: 687
H-index: 8
I10-index: 7
Year
Topic
Type